A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Comparison Study to Determine the Therapeutic Equivalence of GDC 695 and Diclofenac Sodium Gel, 3% in Subjects With Actinic Keratoses
Phase of Trial: Phase III
Latest Information Update: 29 Mar 2018
At a glance
- Drugs GDC 695 (Primary) ; Diclofenac
- Indications Actinic keratosis
- Focus Therapeutic Use
- Sponsors Gage Development
- 26 Mar 2018 Status changed from active, no longer recruiting to completed.
- 01 Aug 2017 Status changed from recruiting to active, no longer recruiting.
- 10 Nov 2016 New trial record